Skip to main content
SpringerLink
Log in

A more detailed description of study methods could be needed: Comments on “Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis”

  • LETTER TO THE EDITOR
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

A LETTER TO THE EDITOR to this article was published on 15 April 2024

The Original Article was published on 31 January 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Amer AS, Abdel Moneam SM, Hashaad NI, Yousef EM, Abd El-Hassib DM (2024) Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis. Clin Rheumatol 43(3):1015–1021

    Article  PubMed  PubMed Central  Google Scholar 

  2. Parodis I, Gokaraju S, Zickert A, Vanarsa K et al (2020) ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford) 59(9):2237–2249

    Article  CAS  PubMed  Google Scholar 

  3. Stanley S, Vanarsa K, Soliman S, Habazi D et al (2020) Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities. Nat Commun 11(1):2197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ding H, Lin C, Cai J, Guo Q et al (2020) Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology. Arthritis Res Ther 22(1):122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chalmers SA, Ayilam Ramachandran R, Garcia SJ, Der E et al (2022) The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. J Clin Invest 132(1):e147334

    Article  PubMed  PubMed Central  Google Scholar 

  6. Fanouriakis A, Kostopoulou M, Andersen J, Aringer M et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15–29

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital of Wenzhou Medical University, 218 Hengjie Road, Taizhou, 318020, Zhejiang, China

    Zhencheng Zhang & Zaixing Yang

Authors
  1. Zhencheng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zaixing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaixing Yang.

Ethics declarations

Disclosures

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Z., Yang, Z. A more detailed description of study methods could be needed: Comments on “Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis”. Clin Rheumatol (2024). https://doi.org/10.1007/s10067-024-06944-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10067-024-06944-1

Search

Navigation